
Mastering Myofibromatosis, Infantile, 2: The Promise of Genetic Testing
Explore the impact of genetic testing in Infantile Myofibromatosis, offering early diagnosis, personalized treatment, and insight into future research developments.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore the impact of genetic testing in Infantile Myofibromatosis, offering early diagnosis, personalized treatment, and insight into future research developments.

Genetic testing for Myopia 23 helps identify mutations, guides personalized care, informs families, and advances research, crucial for managing this rare condition.

Explore Nephronophthisis 15, a rare kidney disorder, and how genetic testing aids in early detection, personalized treatment, and informed family planning.

Explore distal hereditary motor neuronopathy type 5B, its genetic roots, and how genetic testing aids early diagnosis, personalized treatment, and family planning.

Explore how genetic testing aids in diagnosing nonprogressive cerebellar ataxia with intellectual disability, informing personalized care, family planning, and research.

Gain valuable insights into congenital leptin deficiency, a rare genetic obesity disorder. Explore how genetic testing aids in diagnosis, treatment, and family planning.

Unlock insights into obesity caused by leptin receptor gene deficiency. Explore genetic testing's role in diagnosis, treatment customization, and family planning.

Genetic testing in OI type 13 aids diagnosis, management, and personalized treatment through SP7/OSX mutation analysis, improving outcomes for this rare bone disorder.